LISTER TROY (Chief Scientific Officer) sold 23.9% of their position (2.19K shares) of VERVE THERAPEUTICS, INC. on the open market
Open‑market sale worth $9.1K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/3/2025ACC: 0000950170-25-050558
Officer· Chief Scientific Officer
Since Jun 2024
-2.19K
Net shares
Net seller
$9.1K
Total sold
1
Open market trades
0B · 1S
4
Total transactions
7.34K acquired · 9.53K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+7.34K
Price / share
—
Trade value
—
% of position
407.6%
4/1/2025
1.80K→9.14K
Common Stock
Direct
Shares
−2.19K
Price / share
$4.15
Trade value
$9.08K
% of position
23.9%
4/2/2025
9.14K→6.95K
Total
Net shares
+5.15K
Net value
-$9.08K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2025 | M · Option Exercise | +7.34K | — | — | 407.6% | 1.80K | 9.14K |
| Common Stock Direct | 4/2/2025 | S · Sale | −2.19K | $4.15 | $9.08K | 23.9% | 9.14K | 6.95K |
| Total | +5.15K | -$9.08K | ||||||
Derivative Transactions2
Restricted Stock Units
Direct
Converts to
Common Stock
3.31K shares
Shares
−3.31K
Strike price
Held after
6.63K
Exercisable
—
4/1/2025
Restricted Stock Units
Direct
Converts to
Common Stock
4.03K shares
Shares
−4.03K
Strike price
Held after
12.07K
Exercisable
—
4/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock3.31K shares | 4/1/2025 | M · Option Exercise | −3.31K | — | 6.63K | |
| Restricted Stock Units Direct | Common Stock4.03K shares | 4/1/2025 | M · Option Exercise | −4.03K | — | 12.07K |